Skip to main content

Natera, Inc.

NTRA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001604821

In the last 90 days, Natera, Inc. insiders filed 0 open-market purchases and 30 sales; 850 institutions reported holding it in 13F filings for Q2 2026, worth $37.2B in total; 5 superinvestors hold it, including Duquesne Family Office and Coatue Management.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Natera, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
30 filings
8 insiders, $89.6M in total
Insiders trading
8
Net value
−$89.6M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Natera, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Natera, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Sheena JonathanDirector, Other: CO-FOUNDER9,000IndirectSep 25, 202632
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS109,914Sep 18, 202622
Rabinowitz MatthewEXECUTIVE CHAIRMAN0IndirectSep 16, 202615
Chapman Steven LeonardCEO AND PRESIDENT98,199Sep 3, 202617
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER197,257Aug 28, 202615
Brophy Michael BurkesCHIEF FINANCIAL OFFICER51,637Aug 5, 202613
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER170,073Aug 5, 202617
Chapman Rowan EDirector4,663Jul 17, 20268
Botha RoelofDirector4,585Jun 30, 20266
Rosenman HermDirector5,927Jun 30, 20265
Lynch Thomas J. Jr.Director1,905Jun 30, 20261
Baynes Roy D.Director20,158Jun 30, 20265
Marcus Gail BoxerDirector7,852Jun 30, 20265
Bertagnolli MonicaDirector7,020Jun 30, 20264
Rubin EricDirector2,204Jun 30, 20263
Brinkley Ruth WilliamsDirector5,475Apr 28, 20263
Healy JamesDirector46,260Apr 29, 20250
Schueren Robert AlanCHIEF OPERATING OFFICER24,091Jan 31, 20230
Cozzens Todd CDirector15,813May 27, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 10, 2021 (view filing)Sep 10Same dayChapman Steven LeonardCEO AND PRESIDENTSSale−10.1K$119.65−$1.21M−44.0%12.9K after4 lots
Sep 3, 2021 (view filing)Sep 21 dayCozzens Todd CDirectorSSale−24.3K$121.74−$2.95M−50.4%23.9K after3 lots
Sep 1, 2021 (view filing)Aug 30-Sep 12 daysSheena JonathanDirector, Other: CO-FOUNDERSSale−17.9K$121.18−$2.16M−3.8%455.6K after2 lots
Aug 19, 2021 (view filing)Aug 172 daysChapman Rowan EDirectorSSale−5.50K$100.09−$550.5K−53.1%4.86K after
Aug 16, 2021 (view filing)Aug 124 daysChapman Steven LeonardCEO AND PRESIDENTSSale−33.4K$101.66−$3.39M−30.8%75.0K after2 lots
Jul 26, 2021 (view filing)Jul 224 daysSheena JonathanDirector, Other: CO-FOUNDERSSale−1.35K$121.82−$164.7K−0.3%455.6K after3 lots
Jul 26, 2021 (view filing)Jul 224 daysHealy JamesDirectorPPurchase+2.40K$113.00+$271.2KNew position2.40K after
Jul 21, 2021 (view filing)Jul 192 daysChapman Rowan EDirectorSSale−3.00K$108.32−$325.0K−38.2%4.86K after3 lots
Jul 15, 2021 (view filing)Jul 141 dayRabinowitz MatthewEXECUTIVE CHAIRMANSSale−76$116.20−$8.83K0.0%580.1K after
Jul 13, 2021 (view filing)Jul 9-124 daysSheena JonathanDirector, Other: CO-FOUNDERSSale−6.92K$121.09−$837.5K−1.5%455.6K after3 lots
Jul 9, 2021 (view filing)Jul 81 daySchueren Robert AlanCHIEF OPERATING OFFICERSSale−2.03K$113.34−$230.3K−7.5%25.2K after
Jul 7, 2021 (view filing)Jul 6-71 dayChapman Steven LeonardCEO AND PRESIDENTSSale−32.5K$117.18−$3.80M−30.2%75.0K after8 lots